Literature DB >> 15591315

Structural determinants of constitutive androstane receptor required for its glucocorticoid receptor interacting protein-1-mediated nuclear accumulation.

Jun Xia1, Byron Kemper.   

Abstract

Nuclear translocation of constitutive androstane receptor (CAR) is a primary mechanism for the induction of cytochrome P450 genes by phenobarbital (PB). We have shown that exogenous expression of the p160 coactivator glucocorticoid receptor interacting protein-1 (GRIP1) in hepatocytes in vivo can mediate PB-independent nuclear accumulation of murine CAR (mCAR). To understand the mechanism of this PB-independent nuclear accumulation, we have examined the mCAR structural determinants of its GRIP1-mediated nuclear localization. Mutations of the xenobiotic response sequence (XRS), which had been shown to block PB-dependent nuclear translocation of human CAR in mouse hepatocytes in vivo, also blocked GRIP1-mediated nuclear accumulation of mCAR in mouse hepatocytes in vivo and further blocked nuclear localization in cultured HepG2 cells. A leucine 326 XRS mutant retained partial transcriptional activity, but mutations of three leucines in the XRS eliminated transcriptional activity in HepG2 cells, suggesting that the translocation function of the XRS overlaps with transcriptional functions. Mutation of the activation function 2 motif, by deletion of the C-terminal 8 amino acids, also reduced nuclear localization by both PB treatment and GRIP1 expression in hepatocytes in vivo, suggesting that either interaction with GRIP1 through this motif or active CAR was required for the nuclear localization. The localization of a DNA-binding domain mutant was essentially unchanged by coexpression of GRIP1, although without GRIP1 coexpression, this mutant expressed exhibited a more nuclear localization compared with wild type. The results are most consistent with a model in which GRIP1 interaction and activation of mCAR in the nucleus result in retention and accumulation of mCAR in the nucleus in untreated animals. The model requires that mCAR is constantly shuttling between the nucleus and cytoplasm even in untreated animals in which mCAR is predominantly cytoplasmic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591315     DOI: 10.1074/jbc.M409696200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.

Authors:  Yuzhi Jia; Grace L Guo; Sailesh Surapureddi; Joy Sarkar; Chao Qi; Dongsheng Guo; Jun Xia; Papreddy Kashireddi; Songtao Yu; Young-Wook Cho; M Sambasiva Rao; Byron Kemper; Kai Ge; Frank J Gonzalez; Janardan K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

2.  Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.

Authors:  Jun Xia; Lan Liao; Joy Sarkar; Kojiro Matsumoto; Janardan K Reddy; Jianming Xu; Byron Kemper
Journal:  Arch Biochem Biophys       Date:  2007-09-18       Impact factor: 4.013

Review 3.  CAR and PXR: the xenobiotic-sensing receptors.

Authors:  Yoav E Timsit; Masahiko Negishi
Journal:  Steroids       Date:  2006-12-20       Impact factor: 2.668

Review 4.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

5.  Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver.

Authors:  Joy Sarkar; Chao Qi; Dongsheng Guo; Mohamed R Ahmed; Yuzhi Jia; Nobuteru Usuda; Navin Viswakarma; M Sambasiva Rao; Janardan K Reddy
Journal:  Gene Expr       Date:  2007

Review 6.  Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation.

Authors:  Yuliya A Pustylnyak; Lyudmila F Gulyaeva; Vladimir O Pustylnyak
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.